Neural, Behavioral, and Measurement Considerations in the Detection of Motor Impairment

Comprehensive Toxicology, Second Edition

Volumn 13, Issue , 2010, Pages 289-313

  Newland, M C ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Adjustment to impairment; Measurement; Motor function; Neurotoxicology; Operant behavior; Tremor

Indexed keywords

EID: 85012815075     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-046884-6.01318-X     Document Type: Chapter

References (141)

1. Aiba A., Kano M., Chen C., Stanton M.E., Fox G.D., Herrup K., Zwingman T.A., Tonegawa S. Cell 1994, 79:377-388.
2. Alexander G.E., Delong M.S., Strick P.L. Annu. Rev. Neurosci. 1986, 9:357-381.
3. Anger W.K. Neurotoxicol. Teratol. 1984, 6:147-153.
4. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Toxicol. Appl. Pharmacol. 2007, 221:131-147.
5. Ayres P.H., Taylor W.D.In Principles and Methods of Toxicology 1989, 111-135. Raven Press, New York. A.W. Hayes (Ed.).
6. Barbeau A. Neurotoxicology 1984, 1:13-36.
7. Barbeau A., Inoue N., Cloutier T. Adv. Neurol. 1976, 14:339-352.
8. Barnes T.R. Psychiatr. Dev. 1987, 5:301-319.
9. Bendat J.S., Piersol A.G. Random Data: Analysis and Measurement Procedures 1971, Wiley-Interscience, New York.
10. Biernat H., Ellias S.A., Wermuth L., Cleary D., De Oliveira Santos E.C., Jorgensen P.J., Feldman R.G., Grandjean P. Neurotoxicology 1999, 20:945-952.
11. Blough D., Blough P.In Handbook of Operant Behavior 1977, 514-539. Prentice-Hall, Englewood Cliffs, NJ. W.K. Honig, J.E.R. Staddon (Eds.).
12. Bloxham C.A., Mindel T.A., Frith C.D. Brain 1984, 107:371-384.
13. Brooks V.B. The Neural Basis of Motor Control 1986, Oxford Univerisity, New York.
14. Brooks V.B., Kennedy P.R., Ross H.G. Physiol. Behav. 1983, 31:561-563.
15. Brotchie P., Iansek R., Horne M.K. Brain 1991, 114:1667-1683.
16. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. Proc. Natl. Acad. Sci. USA 1983, 80:4546-4550.
17. Caudle W.M., Tillerson J.L., Reverón M.E., Miller G.W. Neurosci. Lett. 2007, 418:213-216.
18. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology 2003, Oxford University, New York.
19. Corfield-Sumner P.K., Stolerman I.P.In Contemporary Research in Behavioral Pharmacology 1978, 391-448. Plenum, New York. D.E. Blackman, D.J. Sanger (Eds.).
20. Cote L., Crutcher M.D.In Principles of Neural Science 1991, 647-659. Appleton & Lange, Norwalk, CT. E.R. Kandel, J.H. Schwartz, T.M.E. Jessell (Eds.).
21. Creese I. Behavioral Pharmacology: The Current Status 1985, 221-241. A.R. Liss, New York.
22. Darling W.G., Cole K.J., Abbs J.H. Exp. Brain Res. 1988, 73:225-235.
23. Day J.J., Reed M.N., Newland M.C. Neurotoxicol. Teratol. 2005, 27:629-641.
24. DeLong M.R., Georgopoulos A.P.In Handbook of Physiology, Section 1: The Nervous System. Motor Control 1981, Vol. 2:1017-1061. American Physiological Society, Bethesda, MD. E.R. Kandel (Ed.).
25. Delong M.R., Georgopoulos A.P., Crutcher M.D., Mitchell R.T., Richardson R.T., Alexander G.E.In Functions of the Basal Ganglia 1984, 74-77. Pitman, London. D. Evered (Ed.).
26. Deuschl G., Raethjen J., Lindemann M., Krack P. Muscle Nerve 2001, 24:716-735.
27. Donlin, W. D. Operant licking: A means for studying manganese neurotoxicity. Psychology. Thesis, Auburn University, Auburn, AL, 2002.
28. Donlin, W. D. The percentile IRT schedule: High-rate behavior as a tool for examining the motor effects of methylmercury exposure. Psychology. Dissertation, Auburn University; Auburn, AL, 2005.
29. Eckerman D.A., Hienz R.D., Stern S., Kowlowitz V. J. Exp. Anal. Behav. 1980, 33:299-310.
30. Eckerman D.A., Lanson R.N. J. Exp. Anal. Behav. 1969, 12:73-80.
31. Elble R.J., Koller W.C. Tremor 1990, Johns Hopkins University, Baltimore, MD.
32. Elsner J., Fellmann C., Zbinden G. Neurotoxicol. Teratol. 1988, 10:3-14.
33. Emmerik R.E.A.V., Sprague R.L., Newell K.M. Exp. Clin. Psychopharmacol. 1993, 1:259-268.
34. Eriksson H., Magiste K., Plantin L., Fonnum F., Hedstrom K., Theodorsson-Norheim E., Kristensson K., Stalberg E. Arch. Toxicol. 1987, 61:46-52.
35. Farahat T.M., Abdelrasoul G.M., Amr M.M., Shebl M.M., Farahat F.M., Anger W.K. Occup. Environ. Med. 2003, 60:279-286.
36. Fechter L.D., Young J.S.In Neurobehavioral Toxicology 1986, 23-42. Johns Hopkins University Press, Baltimore, MD. Z. Annau (Ed.).
37. Findley L.J., Capildeo R. Movement Disorders: Tremor 1984, Oxford University Press, New York.
38. Flowers K. Brain 1978, 101:35-52.
39. Flowers K.A. Brain 1976, 99:269-310.
40. Forssberg H., Johnels B., Steg G. Adv. Neurol. 1984, 40:375-379.
41. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., Zarcone T.J. J. Neurosci. Nurs. 2001, 107:107-124.
42. Fowler S.C., Filewich R.J., Leberer M.R. Pharmacol. Biochem. Behav. 1977, 6:421-426.
43. Fowler S.C., Liao R.M., Skjoldager P. Behav. Neurosci. 1990, 104:449-456.
44. Fowler S.C., McKerchar T.L., Zarcone T.J.In Animal Models of Movement Disorders 2005, 735-753. Elsevier Inc, Burlington, MA. M. LeDoux (Ed.).
45. Fowler S.C., McKerchar T.L., Zarcone T.J.In Animal Models of Movement Disorders 2005, 73-100. Elsevier Inc, Burlington, MA. M. LeDoux (Ed.).
46. Fowler S.C., Skjoldager P.D., Liao R.M., Chase J.M., Johnson J.S. J. Exp. Anal. Behav. 1991, 56:239-260.
47. Freund H.J. Physiol. Rev. 1983, 63:387-436.
48. Freund H.J., Hefter H., Homberg V., Reiners K. Movement Disorders: Tremor 1984, 195-204. Oxford University Press, New York.
49. Gerhart J.M., Hong J.S., Tilson H.A. Toxicol. Appl. Pharmacol. 1983, 70:382-389.
50. Ghez C. Principles of Neural Science 1991, 609-625. Appleton and Lange, Norwalk, CT. E.R. Kandel, J.H. Schwartz, T.M. Jessell (Eds.).
51. Gilbert P.F., Thach W.T. Brain REs. 1977, 128:309-328.
52. Gilbert S.G., Maurissen J.P.J. J. Toxicol. Environ. Health 1982, 10:31-41.
53. Goldstein D.B. Pharmacology of Alcohol 1983, Oxford University Press, New York.
54. Gothoni P. Pharmacol. Biochem. Behav. 1985, 23:339-344.
55. Guilarte T.R., Chen M.K., Mcglothan J.L., Verina T., Wong D.F., Zhou Y., Alexander M., Rohde C.A., Syversen T., Decamp E., et al. Exp. Neurol. 2006, 202:381-390.
56. Harris F.J. Proc. IEEE 1978, 66:51-83.
57. Heath, J. C.; Banna, K. M.; Reed, M. N.; Pesek, E. F.; Cole, N.; Li, J.; Newland, M. C. Neurotoxicology in press.
58. Herr D.W., Hong J.S., Tilson H.A. Psychopharmacology 1985, 86:426-431.
59. Homberg V., Hefter H., Reiners K., Freund H.J. J. Neurol. Neurosurg. Psychiatr. 1987, 50:568-579.
60. Jellinger K.In Handbook of Clinical Neurology: Vol. 5 1986, 465-489. Elsevier. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
61. Jolicoeur F.B., Rondeau D.B., Hamel E., Butterworth R.F., Barbeau A. Can. J. Neurol. Sci. 1979, 6:209-215.
62. Johnston J.M., Pennypacker H.S. Strategies and Tactics of Behavioral Research 1993, L. Erlbaum Associates, Hillsdale, NJ.
63. Kallman M.J., Fowler S.C.In Principles of Neurotoxicology 1994, 373-396. Marcel Dekker, New York. L.W. Chang (Ed.).
64. Karson C.N. Brain 1983, 106:643-653.
65. Koller W.C., Biary N. Neurology 1984, 34:221-222.
66. Kulig B.M., Jaspers R.M.A.In Introduction to Neurobehavioral Toxicology 1999, 70-113. CRC Press, Boca Raton, FL. R.J.M. Niesink, R.M.A. Jaspers, L.M.W. Kornet, J.M. van Ree, H.A. Tilson (Eds.).
67. Kulig B.M., Vanwersch R.A.P., Wolthuis O.L. Toxicol. Appl. Pharmacol. 1985, 80:1-10.
68. Lathers C.M., Smith C.M. J. Pharmacol. Exp. Ther. 1976, 197:126-134.
69. Laties V.G. J. Pharmacol. Exp. Ther. 1972, 183:1-13.
70. Laties V.G. Fed. Proc. 1975, 34:1880-1888.
71. Laties V.G., Weiss B. J. Pharmacol. Exp. Ther. 1966, 152:388-396.
72. Leblanc A.E., Kalant H., Gibbins R.J. Psychopharmacology 1976, 48:153-158.
73. Animal Models of Movement Disorders 2005, Elsevier Inc, Burlington, MA. M. Ledoux (Ed.).
74. Logigian E., Hefter H., Reiners K., Freund H. Ann. Neurol. 1991, 30:172-179.
75. Marsden C.D., Meadows J.C., Lange G.W., Watson R.S. Electroencephalogr. Clin. Neurophysiol. 1969, 27:169-178.
76. Marsh D.O.In The Toxicity of Methyl Mercury 1987, 45-53. Johns Hopkins University Press, Baltimore, MD. C.U. Eccles, Z. Annau (Eds.).
77. Maurissen J.P., Marable B.R., Andrus A.K., Stebbins K.E. Neurotoxicol. Teratol. 2003, 25:543-553.
78. Martin J.P. The Basal Ganglia and Posture 1967, Pitman, London.
79. Mccauley L.A., Anger W.K., Keifer M., Langley R., Robson M.G., Rohlman D. Environ. Health Perspect. 2006, 114:953-960.
80. Metz G.A., Kolb B., Whishaw I.Q.In The Behavior of the Laboratory Rat 2005, 594-602. Oxford University Press, Oxford. I.Q. Whishaw, B. Kolb (Eds.).
81. Miall R.C., Weir D.J., Stein J.F. Behav. Brain Res. 1988, 27:1-8.
82. Milner T.E. Exp. Brain Res. 1986, 62:99-110.
83. Moser V.C. Neurotoxicol. Teratol. 1990, 12:483-488.
84. Neff N.H., Barrett R.E., Costa E. Experientia 1969, 25:1140-1141.
85. Newland M.C. Toxicol. Lett. 1988, 43:295-319.
86. Newland M.C.In Neurobehavioral Toxicity: Analysis and Interpretation 1994, 273-297. Raven Press, New York. B. Weiss, J.L. O'Donoghue (Eds.).
87. Newland M.C.In Neurotoxicology: Approaches and Methods 1995, 265-299. Academic Press, San Diego, CA. L.W. Chang, W. Slikker (Eds.).
88. Newland M.C. Neurotoxicology 1999, 20:415-432.
89. Newland M.C., Ceckler T.L., Kordower J.H., Weiss B. Exp. Neurol. 1989, 106:251-258.
90. Newland M.C., Rasmussen E.B. Neurotoxicol. Teratol. 2000, 22:819-828.
91. Newland M.C., Weiss B. Pharmacol. Biochem. Behav. 1990, 36:381-387.
92. Newland M.C., Weiss B. J. Stud. Alcohol 1991, 52:492-499.
93. Newland M.C., Weiss B. Toxicol. Appl. Pharmacol. 1992, 113:87-97.
94. Newland M.C., Yezhou S., Logdberg B., Berlin M. Toxicol. Appl. Pharmacol. 1994, 126:6-15.
95. Notterman J.M., Mintz D.E. Dynamics of Response 1965, Wiley, New York.
96. O'Keeffe R.T., Lifshitz K. J. Am. Coll. Toxicol. 1989, 8:127-140.
97. Olanow C.W., Good P.F., Shinotoh H., Hewitt K.A., Vingerhoets F., Snow B.J., Beal M.F., Calne D.B., Perl D.P. Neurology 1996, 46:492-498.
98. Parent A. Trends Neurosci. 1990, 13:254-258.
99. Pisa M. Neuroscience 1988, 24:453-463.
100. Pozos R.S., Iaizzo P.A., Petry R.W. J. Appl. Physiol. 1982, 52:226-230.
101. Pryor G.T., Uyeno E.T., Tilson H.A., Mitchell C.L. Neurotoxicol. Teratol. 1983, 5:91-117.
102. Rees D.C., Wood R.W., Laties V.G. J. Exp. Anal. Behav. 1985, 43:243-255.
103. Reuhl K.R., Chang L.W. Neurotoxicology 1979, 1:21-55.
104. Rice D.C.In Neurobehavioral Toxicity: Analysis and Interpretation 1994, 299-318. Raven Press, New York. B. Weiss, J.L. O'Donoghue (Eds.).
105. Richter R. J. Neuropathol. Exp. Neurol. 1945, 4:324-353.
106. Roels H., Malchaire J., Wambeke J.P.V., Buchet J.P. J. Occup. Health 1983, 25:481-487.
107. Schneider J.S., Decamp E., Koser A.J., Fritz S., Gonczi H., Syversen T., Guilarte T.R. Brain Res. 2006, 1118:222-231.
108. Schuster C.R., Dockens W.S., Woods J.H. Psychopharmacology 1966, 9:170-182.
109. Sette W.F.In Neurobehavioral Toxicity: Analysis and Interpretation 1994, 231-242. Raven, New York. B. Weiss, J.L. O'Donoghue (Eds.).
110. Sette W.F., Levine T.E. Neurobehavioral Toxicology 1986, 391-403. Johns Hopkins University Press, Baltimore, MD. Z. Annau (Ed.).
111. Sprague R.L., Deutsch K.M., Newell K.M. Am. J. Ment. Retard. 2007, 112:300-307.
112. Stanton M.E., Freeman J.H., Skelton R.W. Behav. Neurosci. 1992, 106:657-665.
113. Stern Y., Mayeux R., Rosen J., Ilson J. J. Neurol. Neurosurg. Psychiatr. 1983, 46:145-151.
114. Stevens S.S. Handbook of Experimental Psychology 1951, Wiley, New York.
115. Stine W.W. Psychol. Bull. 1989, 105:147-155.
116. Tang M., Lau C.E., Falk J.L. J. Pharmacol. Exp. Ther. 1988, 246:1053-1060.
117. Taub E., Uswatte G. J. Rehabil. Med. 2003, 41:34-40.
118. Taub E., Uswatte G., Elbert T. Nat. Rev. Neurosci. 2002, 3:228-236.
119. Taub E., Uswatte G., Mark V.W., Morris D.M. Eur. Medicophys. 2006, 42:241-256.
120. Thach W.T., Goodkin H.P., Keating J.G. Annu. Rev. Neurosci. 1992, 15:403-442.
121. Thach W.T., Montgomery E.B. Neurobiology of Disease 1990, 168-196. Oxford University, New York. A.L. Pearlmon, R.C. Collins (Eds.).
122. Thompson D.M., Moerschbaecher J. Neurobiol. Learn. Mem. 1978, 26:277-287.
123. Thompson D.M., Moerschbaecher J.M. Advances in Behavioral Pharmacology 1979, 2:229-255. Academic Press, New York. T. Thompson, P.B. Dews (Eds.).
124. Thompson R.F., Thompson J.K., Kim J.J., Krupa D.J., Shinkman P.G. Neurobiol. Learn. Mem. 1998, 70:150-176.
125. Tilson H.A., Cabe P.A. Life Sci. 1978, 23:1365-1370.
126. Tilson H.A., Moser V.C. Neurotoxicology 1992, 13:1-14.
127. Vanderwolf C.H., Kolb B., Cooley R.K. J. Comp. Physiol. Psychol. 1978, 92:156-175.
128. Wade P., Gresty M.A., Findley L.J. Arch. Neurol. 1982, 39:358-362.
129. Wahlsten D., Metten P., Phillips T.J., Boehm S.L., Burkhart-Kasch S., Dorow J., Doerksen S., Downing C., Fogarty J., Rodd-Henricks K., et al. J. Neuroendocrinol. 2003, 54:283-311.
130. Wang G., Fowler S.C. Psychopharmacology 1999, 147:38-45.
131. Wang G., Fowler S. Psychopharmacology 2001, 158:273-280.
132. Weiss B., Cory-Slechta D.A.In Principles and Methods of Toxicology 1994, 1091-1155. Raven Press, New York. A.W. Hayes (Ed.).
133. Weiss B., Santelli S., Lusink G. Psychopharmacology 1977, 53:289-293.
134. Whishaw I.Q.In The Cerebral Cortex of the Rat 1990, 239-267. The MIT Press, Cambridge, MA. B. Kolb, R. Tees (Eds.).
135. Whishaw I.Q., Kolb B. Physiol. Behav. 1983, 30:471-480.
136. Whishaw I.Q., Kolb B. Behav. Brain Res. 1989, 32:101-113.
137. Wood R.W., Weiss A.B., Weiss B. Arch. Environ. Health 1973, 26:249-252.
138. Wyatt R.H. IEEE Trans. Biomed. Eng. 1968, BME-15:33-45.
139. Wylie R.M., Tyner C.F. Behav. Neurosci. 1989, 103:273-282.
140. Youssef A.F., Weiss B., Cox C. Neurotoxicol. Teratol. 1993, 15:223-227.
141. Zeiler M.In Handbook of Operant Behavior 1977, 201-232. Prentice-Hall, Englewood Cliffs, NJ. W.K. Honig, J.E.R. Staddon (Eds.).